Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...

Researchers have found that antigen-specific killer T cells (CD8+ T cells) rapidly expand in the lungs when primed by antigen-presenting lung-resident alveolar macrophages (AMs). This interaction ...

Researchers have discovered that lung-based immune cells can be "trained" to remember a previously encountered pathogen, making them more efficient at clearing out the cellular debris that accumulates ...

Lungs are highly vulnerable to injury and infection due to continuous exposure to inhaled environmental pathogens and particles. As a result, respiratory diseases are a leading cause of disability and ...

Computed Tomographic Scan of the Chest of a 41-Year-Old Man, Showing Bilateral Calcific, Micronodular Opacities. The sister subsequently had a mild restrictive respiratory defect, but she is still ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

The human immune system is a highly complex network of cells, signals, and responses that is tightly regulated to ensure that the body can fight off infection without damaging its own tissues. Now, ...